Saudi Chemical Holding 過去の業績
過去 基準チェック /56
Saudi Chemical Holdingは、平均年間39.4%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間20.3% 13.8%収益成長率で 成長しています。 Saudi Chemical Holdingの自己資本利益率は16%であり、純利益率は5.4%です。
主要情報
39.4%
収益成長率
39.4%
EPS成長率
| Healthcare 業界の成長 | 12.3% |
| 収益成長率 | 13.8% |
| 株主資本利益率 | 16.0% |
| ネット・マージン | 5.4% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Here's Why Saudi Chemical Holding (TADAWUL:2230) Has Caught The Eye Of Investors
Oct 24
There's Been No Shortage Of Growth Recently For Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital
Sep 09Saudi Chemical Holding Company's (TADAWUL:2230) P/E Is On The Mark
May 28Investors Met With Slowing Returns on Capital At Saudi Chemical Holding (TADAWUL:2230)
May 07With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case
Mar 06Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors
Feb 10Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return
Oct 31Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today
Jul 06Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50
Jan 09Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50
Dec 22Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital
Sep 14Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around
Dec 06Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?
Apr 19Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital
Mar 29Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?
Mar 01Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?
Feb 01
How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?
Dec 28Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?
Nov 30収支内訳
収支内訳
Saudi Chemical Holding の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 6,022 | 326 | 364 | 0 |
| 30 Jun 24 | 5,869 | 288 | 370 | 0 |
| 31 Mar 24 | 5,460 | 242 | 368 | 0 |
| 31 Dec 23 | 4,855 | 183 | 356 | 0 |
| 30 Sep 23 | 4,521 | 117 | 353 | 0 |
| 30 Jun 23 | 4,081 | 93 | 336 | 0 |
| 31 Mar 23 | 3,831 | 80 | 322 | 0 |
| 31 Dec 22 | 3,696 | 80 | 310 | 0 |
| 30 Sep 22 | 3,378 | 51 | 295 | 0 |
| 30 Jun 22 | 3,402 | 48 | 285 | 0 |
| 31 Mar 22 | 3,346 | 61 | 292 | 0 |
| 31 Dec 21 | 3,411 | 70 | 290 | 0 |
| 30 Sep 21 | 3,491 | 53 | 264 | 0 |
| 30 Jun 21 | 3,517 | 64 | 270 | 0 |
| 31 Mar 21 | 3,476 | 77 | 259 | 0 |
| 31 Dec 20 | 3,306 | 74 | 267 | 0 |
| 30 Sep 20 | 3,066 | 46 | 328 | 0 |
| 30 Jun 20 | 2,991 | 41 | 340 | 0 |
| 31 Mar 20 | 2,909 | 32 | 342 | 0 |
| 31 Dec 19 | 2,949 | 33 | 334 | 0 |
| 30 Sep 19 | 3,226 | 101 | 301 | 0 |
| 30 Jun 19 | 3,120 | 101 | 280 | 0 |
| 31 Mar 19 | 2,998 | 98 | 263 | 0 |
| 31 Dec 18 | 2,949 | 115 | 245 | 0 |
| 30 Sep 18 | 2,768 | 128 | 220 | 0 |
| 30 Jun 18 | 2,650 | 143 | 211 | 0 |
| 31 Mar 18 | 2,541 | 143 | 209 | 0 |
| 31 Dec 17 | 2,474 | 142 | 211 | 0 |
| 30 Sep 17 | 2,274 | 129 | 196 | 0 |
| 30 Jun 17 | 2,206 | 119 | 196 | 0 |
| 31 Mar 17 | 2,279 | 138 | 197 | 0 |
| 31 Dec 16 | 2,143 | 134 | 194 | 0 |
| 30 Sep 16 | 2,258 | 168 | 212 | 0 |
| 30 Jun 16 | 2,303 | 185 | 210 | 0 |
| 31 Mar 16 | 2,320 | 216 | 210 | 0 |
| 31 Dec 15 | 2,410 | 251 | 207 | 0 |
| 30 Sep 15 | 2,413 | 266 | 190 | 0 |
| 30 Jun 15 | 2,452 | 270 | 196 | 0 |
| 31 Mar 15 | 2,470 | 279 | 187 | 0 |
| 31 Dec 14 | 2,484 | 284 | 186 | 0 |
| 30 Sep 14 | 2,566 | 292 | 189 | 0 |
| 30 Jun 14 | 2,450 | 313 | 172 | 0 |
| 31 Mar 14 | 2,359 | 303 | 169 | 0 |
| 31 Dec 13 | 2,275 | 301 | 163 | 0 |
質の高い収益: 2230は 高品質の収益 を持っています。
利益率の向上: 2230の現在の純利益率 (5.4%)は、昨年(2.6%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 2230の収益は過去 5 年間で年間39.4%増加しました。
成長の加速: 2230の過去 1 年間の収益成長率 ( 178.1% ) は、5 年間の平均 ( 年間39.4%を上回っています。
収益対業界: 2230の過去 1 年間の収益成長率 ( 178.1% ) はHealthcare業界15.7%を上回りました。
株主資本利益率
高いROE: 2230の 自己資本利益率 ( 16% ) は 低い とみなされます。